Zal AI het volgende hoofdstuk schrijven in literatuurreviews?

In the past 10 years, the rapid expansion of oncology knowledge, with numerous new therapeutic targets, drug approvals, early interventions, and an exponentially increased number of clinical trials, has dramatically complexified treatment algorithms and been responsible for a significant rise in cancer-related survival rates.1,2 International guidelines often struggle to keep pace with the rapid advancements of discoveries and regulatory approvals, and even major conferences, typically spaced months apart, may not disseminate practice-changing updates quickly enough to impact daily medical practice.